Cardica To Host Business Update Conference Call

REDWOOD CITY, Calif., March 25, 2015 /PRNewswire/ -- Cardica, Inc. (Nasdaq: CRDC) today announced that it will hold a business update conference call on Thursday, March 26, 2015, at 8:30 a.m. Eastern Time to provide an update on the company's business. In addition, the company will file a Current Report on Form 8-K with the Securities and Exchange Commission prior to the call, which will be available at www.cardica.com.

Conference Call Details
To access the live conference call on March 26, 2015, at 8:30 a.m. Eastern Time via phone, please dial 866-543-6403 from the United States and Canada or 617-213-8896 internationally. The conference ID is 82773838. Please dial in approximately 10 minutes prior to the start of the call. A telephone replay will be available beginning approximately four hours after the call through April 2, 2015, and may be accessed by dialing 888-286-8010 from the United States and Canada or 617-801-6888 internationally. The replay passcode is 85001711.

To access the live and subsequently archived webcast of the conference call, go to the Investor Relations section of the company's website at www.cardica.com. Please connect to the website at least 15 minutes prior to the presentation to allow for any necessary software downloads.

The webcast is also being distributed through the Thomson StreetEvents Network. Institutional investors can access the call via Thomson StreetEvents at www.streetevents.com, a password-protected event management site.

About Cardica
Cardica designs and manufactures proprietary stapling and anastomotic devices for cardiac and laparoscopic surgical procedures. Cardica's technology portfolio is intended to reduce operating time and facilitate minimally-invasive and robot-assisted surgeries. Cardica's MicroCutter XCHANGE^® 30, a cartridge-based articulating surgical stapling device with a five-millimeter shaft diameter, is manufactured and cleared for use in a variety of gastrointestinal procedures and appendectomies in the United States, and for a wide range of surgical procedures in Europe. In addition, Cardica manufactures and markets its automated anastomosis systems, the C-Port^® Distal Anastomosis Systems and PAS-Port^® Proximal Anastomosis System for coronary artery bypass graft (CABG) surgery, and has shipped over 53,000 units throughout the world.

SOURCE Cardica, Inc.

Related Links

http://www.cardica.com